Log in

ANI Pharmaceuticals Price Target & Analyst Ratings (NASDAQ:ANIP)

$74.59
+1.20 (+1.64 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$73.40
Now: $74.59
$75.26
50-Day Range
$64.72
MA: $70.88
$76.53
52-Week Range
$36.92
Now: $74.59
$86.96
Volume132,929 shs
Average Volume132,389 shs
Market Capitalization$902.54 million
P/E Ratio16.18
Dividend YieldN/A
Beta2.23

Analyst Ratings

ANI Pharmaceuticals (NASDAQ:ANIP) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for ANI Pharmaceuticals in the last 12 months. Their average twelve-month price target is $84.25, suggesting that the stock has a possible upside of 12.95%. The high price target for ANIP is $90.00 and the low price target for ANIP is $76.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $84.25$84.25$87.00$72.33
Price Target Upside: 12.95% upside20.98% upside18.87% upside9.95% upside

ANI Pharmaceuticals (NASDAQ:ANIP) Consensus Price Target History

ANI Pharmaceuticals (NASDAQ:ANIP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/12/2019GuggenheimInitiated CoverageBuy$76.00High
5/13/2019Canaccord GenuityReiterated RatingPositive ➝ Buy$80.00 ➝ $90.00High
5/10/2019Raymond JamesDowngradeStrong-Buy ➝ Outperform$73.00 ➝ $82.00Low
5/9/2019Cantor FitzgeraldReiterated RatingBuy$89.00Medium
(Data available from 10/19/2017 forward)
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel